Codexis Inc (CDXS)

Codexis Inc (CDXS) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $145M; returns 1 day -2.3%, 1 week +3.2%, 1 year -50.6%.

Codexis, Inc. is an enzyme engineering company that leverages its proprietary CodeEvolver® technology platform to discover, develop, and commercialize novel, high-performance enzymes. The company's business is centered on two primary areas.

Groups CDXS belongs to

• Biotechnology
• Life Sciences
• Healthcare
• Pharmaceuticals
• Life Sciences Tools & Services
• Manufacturing
• Contract Development and Manufacturing Organizations (CDMO)
• Industrial Technology
• Drug Discovery

CDXS financial model: income statement, cash flow and balance sheet